SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-026294
Filing Date
2021-05-11
Accepted
2021-05-11 07:48:05
Documents
14
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K beam-8k_20210511.htm   iXBRL 8-K 37333
2 EX-99.1 beam-ex991_6.htm EX-99.1 119975
3 GRAPHIC gb4m3aoeiuwz000001.jpg GRAPHIC 12177
  Complete submission text file 0001564590-21-026294.txt   313613

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA beam-20210511.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20210511_lab.xml EX-101.LAB 19466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20210511_pre.xml EX-101.PRE 11621
7 EXTRACTED XBRL INSTANCE DOCUMENT beam-8k_20210511_htm.xml XML 3546
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 21909645
SIC: 2836 Biological Products, (No Diagnostic Substances)